BenevolentAI is a pioneer and leader in applying advanced AI to drug discovery and development.
In a world where drug development failure rate exceeds 90% and thousands of complex diseases lack treatment, our technology can increase the probability of success and reduce timelines.
Our proprietary Benevolent PlatformTM is one of the industry's most established and validated AI drug discovery technologies. Expertise across Target Identification, Chemistry and Drug Repurposing enables us to deliver across the entire R&D lifecycle. We unite science and technology to serve patients with complex diseases – because it matters.
BenevolentAI is headquartered in London, UK.
Company Details
- Employees
- 81
- Founded
- -
- Address
- Maple Street, 4-8,united Kingdom
- Phone
- +44 2037 819 360
- he****@****lent.ai
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- benevolent.com
- Keywords
- Artificial Intelligence, Drug Development, Machine Learning, Deep Learning, Big Data, Drug Discovery, Technology, Pharmaceuticals, TechBio.
- HQ
- London, Greater London
Benevolentai Questions
Benevolentai's helpline number is +44 2037 819 360
Benevolentai's website is benevolent.com
Benevolentai's LinkedIn profile is https://www.linkedin.com/company/benevolentai
Benevolentai has
81 employees.
View email and phone details for 81
employees at Benevolentai.
Benevolentai's industry is
Software Development
Benevolentai's top competitors are
Labgenius Therapeutics,
Owkin,
Healx,
Exscientia,
Atomwise,
Recursion,
Isomorphic Labs,
Insilico Medicine,
Insitro,
Google Deepmind.
Benevolentai's support email address is hello@benevolent.ai
Benevolentai's categories are Software Development
Benevolentai's founding year is 2013
